A retrospective analysis of the pharmacovigilance data registry in a tertiary teaching hospital in Jordan

References

• Aagaard, L., Strandell, J., Melskens, L., Petersen, P. S. G., & Hansen, E. H. (2012). Global patterns of adverse drug reactions over a decade: Analyses of spontaneous reports to VigiBase™. Drug Safety, 35(12), 1171–1182. https://doi.org/10.1007/BF03262002
   PubMed Web of Science ®Google Scholar
• Abu Farha, R., Abu Hammour, K. H., Rizik, M., Aljanabi, R., & Alsakran, L. (2018). Effect of educational intervention on healthcare providers knowledge and perception towards pharmacovigilance: A tertiary teaching hospital experience. Saudi Pharmaceutical Journal, 26(5), 611–616. https://doi.org/10.1016/j.jsps.2018.03.002
   PubMed Web of Science ®Google Scholar
• Abu Hammour, K., El-Dahyat, F., & Abu Farha, R. (2017). Health care professionals knowledge and perception of pharmacovigilance in a tertiary care teaching hospital in Amman, Jordan JECP First published: 16 January 2017 https://doi.org/10.1111/jep.12683.
   Google Scholar
• Alomar, M., Tawfiq, A. M., Hassan, N., & Palaian, S. (2020). Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: Current status, challenges and the future. Therapeutic Advances in Drug Safety, 11, 204209862093859. https://doi.org/10.1177/2042098620938595
   Web of Science ®Google Scholar
• Alsbou, M., Abdeen, G., Batarseh, A., Bawaresh, N., Jaber, J., & Qawasmi, G. (2017). Analysis of the national pharmacovigilance database in Jordan (2010–2014). Biomedical and Pharmacology Journal, 10(1), 319–328. https://doi.org/10.13005/bpj/1112
   Google Scholar
• Alsbou, M., Alzubiedi, S., Alzobi, H., Samhadanah, N. A., Alsaraireh, Y., Alrawashdeh, O., Aqel, A., & Al-Salem, K. (2015). Adverse drug reactions experience in a teaching hospital in Jordan. International Journal of Clinical Pharmacy, 37(6), 1188–1193. https://doi.org/10.1007/s11096-015-0185-1
   PubMed Web of Science ®Google Scholar
• Awwad, O., Abu Farha, R., Altaharwah, A., Sharaya, S., Naser, A. Y., & Tabaza, H. (2024). Acute COPD exacerbations and in-hospital treatment-related problems: An observational study. PLoS One, 19(6), e0305011. https://doi.org/10.1371/journal.pone.0305011
   PubMed Web of Science ®Google Scholar
• Beninger, P. (2018). Pharmacovigilance: An overview. Clinical Therapeutics, 40(12), 1991–2004. https://doi.org/10.1016/j.clinthera.2018.07.012
   PubMed Web of Science ®Google Scholar
• Bouvy, J. C., De Bruin, M. L., & Koopmanschap, M. A. (2015). Epidemiology of adverse drug reactions in Europe: A review of recent observational studies. Drug Safety, 38(5), 437–453. https://doi.org/10.1007/s40264-015-0281-0
   PubMed Web of Science ®Google Scholar
• Buxbaum, J. D., Chernew, M. E., Fendrick, A. M., & Cutler, D. M. (2020). Contributions Of public health, pharmaceuticals, And other medical care To US life expectancy changes, 1990–2015: Study examines the conditions most responsible for changing US life expectancy and how public health, pharmaceuticals, other medical care, and other factors may have contributed to the changes. Health Affairs, 39(9), 1546–1556. https://doi.org/10.1377/hlthaff.2020.00284
   PubMed Web of Science ®Google Scholar
• dos Santos, D. B., & Coelho, H. L. L. (2006). Adverse drug reactions in hospitalized children in fortaleza, Brazil. Pharmacoepidemiology and Drug Safety, 15(9), 635–640. https://doi.org/10.1002/pds.1187
   PubMed Web of Science ®Google Scholar
• El-Dahiyat, F., Abu Hammour, K., Abu Farha, R., Manaseer, Q., Momani, A. A., & Allan, A. (2023a). The impact of educational interventional session on healthcare providers knowledge about pharmacovigilance at a tertiary Jordanian teaching hospital. Journal of Pharmaceutical Policy and Practice, 16(1), 56. https://doi.org/10.1186/s40545-023-00561-0
   PubMed Web of Science ®Google Scholar
• El-Dahiyat, F., Hammour, K. A., Farha, R. A., Manaseer, Q., Allan, A., & Alkhawaldeh, R. (2023b). Jordanians’ knowledge, attitude and practice regarding adverse drug reactions reporting. Saudi Pharmaceutical Journal, 31(7), 1197–1201. https://doi.org/10.1016/j.jsps.2023.05.016
   PubMed Web of Science ®Google Scholar
• Formica, D., Sultana, J., Cutroneo, P. M., Lucchesi, S., Angelica, R., Crisafulli, S., Ingrasciotta, Y., Salvo, F., Spina, E., & Trifirò, G. (2018). The economic burden of preventable adverse drug reactions: A systematic review of observational studies. Expert Opinion on Drug Safety, 17(7), 681–695. https://doi.org/10.1080/14740338.2018.1491547
   PubMed Web of Science ®Google Scholar
• Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998). Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. Jama, 279(15), 1200–1205. https://doi.org/10.1001/jama.279.15.1200
   PubMed Web of Science ®Google Scholar
• Li, R., Curtis, K., Zaidi, S. T. R., Van, C., Thomson, A., & Castelino, R. (2021). Prevalence, characteristics, and reporting of adverse drug reactions in an Australian hospital: A retrospective review of hospital admissions due to adverse drug reactions. Expert Opinion on Drug Safety, 20(10), 1267–1274. https://doi.org/10.1080/14740338.2021.1938539
   PubMed Web of Science ®Google Scholar
• Ogar, C. K., Abiola, A., Yuah, D., Ibrahim, A., Oreagba, I. A., Amadi, E. C., Adeyeye, M. C., & Oshikoya, K. A. (2019). A retrospective review of serious adverse drug reaction reports in the Nigerian VigiFlow database from September 2004 to December 2016. Pharmaceutical Medicine, 33(2), 145–157. https://doi.org/10.1007/s40290-019-00267-2
   PubMed Web of Science ®Google Scholar
• Shroukh, W. A., Shakhatreh, F. M., Yasein, N. A., & Sharkas, G. F. (2018). A survey on the knowledge, attitudes and practices of physicians towards pharmacovigilance in Jordanian health centres. International Health, 10(5), 363–370. https://doi.org/10.1093/inthealth/ihy029
   PubMed Web of Science ®Google Scholar
• Tabaza, H., Abu Farha, R., Naser, A., & Awwad, O. (2023). Treatment-related problems and their cost among patients hospitalised with asthma exacerbation. Journal of Pharmaceutical Health Services Research, 14(3), 359–366. https://doi.org/10.1093/jphsr/rmad027
   Web of Science ®Google Scholar
• Thakare, V., Patil, A., Jain, M., Rai, V., & Langade, D. (2022). Adverse drug reactions reporting: Five years analysis from a teaching hospital. Journal of Family Medicine and Primary Care, 11(11), 7316–7321. https://doi.org/10.4103/jfmpc.jfmpc_1043_22
   PubMedGoogle Scholar
• Thomas, F., Abiri, O. T., Komeh, J. P., Conteh, T. A., Bah, A. J., Kanu, J. S., Terry, R., Abrahamyan, A., Thekkur, P., & Zachariah, R. (2022). Inconsistent country-wide reporting of adverse drug reactions to antimicrobials in Sierra Leone (2017–2021): A wake-Up call to improve reporting. International Journal of Environmental Research and Public Health, 19(6), 3264. https://doi.org/10.3390/ijerph19063264
   PubMed Web of Science ®Google Scholar
• Tripathy, R., Das, S., Das, P., Mohakud, N. K., & Das, M. (2021). Adverse drug reactions in the pediatric population: Findings from the adverse drug reaction monitoring center of a teaching hospital in Odisha (2015–2020). Cureus, 13(11).
   Web of Science ®Google Scholar
• WHO (2002). Safety of medicines: A guide to detecting and reporting adverse drug reactions: Why health professionals need to take action. WHO.
   Google Scholar
• WHO (2022). Members of the WHO programme for international drug monitoring. WHO.
   Google Scholar
• Yousef, N. B., Yenugadhati, N., Alqahtani, N., Alshahrani, A., Alshahrani, M., Al Jeraisy, M., & Badri, M. (2022). Patterns of adverse drug reactions (ADRs) in Saudi Arabia. Saudi Pharmaceutical Journal, 30(1), 8–13. doi:10.1016/j.jsps.2021.08.014
   PubMed Web of Science ®Google Scholar